Bryan Simmons
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Bryan Simmons has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Stephen B. Kritchevsky
Department of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest University School of Medicine , Winston-Salem, North Carolina
4 shared publications - Barbara I. Braun
The Joint Commission
1 shared publication James P. Steinberg
Emory University School of Medicine
1 shared publicationMichael S. Gelfand
From the Department of Infectious Diseases, Methodist Central Hospital, Memphis, Tennessee, and the Department of Preventive Medicine, University of Tennessee, Memphis, Tennessee (SBK)
1 shared publicationSusan Chow
From the Department of Infectious Diseases, Methodist Central Hospital, Memphis, Tennessee, and the Department of Preventive Medicine, University of Tennessee, Memphis, Tennessee (SBK)
1 shared publicationWilliam Greene
From the Department of Infectious Diseases, Methodist Central Hospital, Memphis, Tennessee, and the Department of Preventive Medicine, University of Tennessee, Memphis, Tennessee (SBK)
1 shared publication
Latest Publications
- Open Access
- 1 February 2011
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 32 (2) , 163-165
History of SHEA-Sponsored Research: Time to Pass the Torch
Since its inception, the Society for Healthcare Epidemiology of America (SHEA) has promoted research into prevention of adverse events in hospitals. In 1995, SHEA made this mission concrete by initiating a collaborative research project with the Joint Commission on the Accreditation of Health Care Organization (now known as the Joint Commission). In the early 1990s, the Joint Commission was implementing its “Agenda for Change” and associated Indicator Monitoring System. At the time, there were numerous competing measurement systems that used different definitions, all aimed at measuring the quality of patient care, and many had indicators measuring the incidence of hospital-acquired infections. Some of these indicators used administrative data, such as International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes, to measure adverse events.
- 1 February 2011
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 32 (2) , 163-165
Open AccessHistory of SHEA-Sponsored Research: Time to Pass the Torch
Since its inception, the Society for Healthcare Epidemiology of America (SHEA) has promoted research into prevention of adverse events in hospitals. In 1995, SHEA made this mission concrete by initiating a collaborative research project with the Joint Commission on the Accreditation of Health Care Organization (now known as the Joint Commission). In the early 1990s, the Joint Commission was implementing its “Agenda for Change” and associated Indicator Monitoring System. At the time, there were numerous competing measurement systems that used different definitions, all aimed at measuring the quality of patient care, and many had indicators measuring the incidence of hospital-acquired infections. Some of these indicators used administrative data, such as International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes, to measure adverse events.
- 1 March 1997
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 6 (3) , 177-181
Decrease in Candidemia Rates Associated with Empiric Use of Amphotericin B and Fluconazole for Nosocomial Fever of Unknown Origin
Since 1986, patients with nosocomial fever of unknown origin (NFUO) at Methodist Central Hospital (Memphis) have been initially treated with antibacterial antibiotics if there was a likelihood of infection. If there was no response to therapy and noninfectious causes for the NFUO were eliminated, treatment was then initiated with antifungal agents, notably amphotericin B and fluconazole. Most patients so treated were nonneutropenic and in the intensive care unit (ICU). A retrospective analysis using hospital data collected between 1987 and 1994 suggested that hospitalized patients had an increasing severity of illness during the study period yet a decreasing incidence of candidemia, particularly after 1990 when fluconazole was approved and used frequently for NFUO. From 1988 to 1990, the rate of candidemia per 1000 ICU admissions was 5.56; while from 1991 to 1994, the rate was 2.64 per 1000 ICU admissions (P <.0001). Since the data suggest that early empiric therapy of NFUO with antifungal agents is useful when a patient is at high risk for deepseated candidiasis, a prospective study to evaluate this method of clinical management is indicated.
- 1 March 1997
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 6 (3) , 177-181
Decrease in Candidemia Rates Associated with Empiric Use of Amphotericin B and Fluconazole for Nosocomial Fever of Unknown Origin
Since 1986, patients with nosocomial fever of unknown origin (NFUO) at Methodist Central Hospital (Memphis) have been initially treated with antibacterial antibiotics if there was a likelihood of infection. If there was no response to therapy and noninfectious causes for the NFUO were eliminated, treatment was then initiated with antifungal agents, notably amphotericin B and fluconazole. Most patients so treated were nonneutropenic and in the intensive care unit (ICU). A retrospective analysis using hospital data collected between 1987 and 1994 suggested that hospitalized patients had an increasing severity of illness during the study period yet a decreasing incidence of candidemia, particularly after 1990 when fluconazole was approved and used frequently for NFUO. From 1988 to 1990, the rate of candidemia per 1000 ICU admissions was 5.56; while from 1991 to 1994, the rate was 2.64 per 1000 ICU admissions (P <.0001). Since the data suggest that early empiric therapy of NFUO with antifungal agents is useful when a patient is at high risk for deepseated candidiasis, a prospective study to evaluate this method of clinical management is indicated.
- 1 February 1995
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 16 (2) , 101-104
Epidemiologic Approaches to Quality Assessment
Hospital epidemiologists have an opportunity to apply their skills to hospital quality problems other than infection control. Soon, hospitals will be required to collect and report numerous quality indicators, whose results will require epidemiologic interpretation. For those who choose to make the transition into quality management, careful assessment and planning are needed to succeed
- 1 February 1995
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 16 (2) , 101-104
Epidemiologic Approaches to Quality Assessment
Hospital epidemiologists have an opportunity to apply their skills to hospital quality problems other than infection control. Soon, hospitals will be required to collect and report numerous quality indicators, whose results will require epidemiologic interpretation. For those who choose to make the transition into quality management, careful assessment and planning are needed to succeed
- 1 February 1994
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 15 (2) , 116-119
Variation in Medical Practice: Implications for the Hospital Epidemiologist
- 1 February 1994
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 15 (2) , 116-119
Variation in Medical Practice: Implications for the Hospital Epidemiologist